Antifibrotic potential of bone marrow‑derived mesenchymal stem cells in biliary atresia mice

Lei,Jun; Chai,Yong; Xiao,Juhua; Hu,Huakun; Liu,Zhiqiang; Xiao,Yu; Yi,Lijun; Huang,Jinshi; Xiang,Tianxin; Zhang,Shouhua

doi:10.3892/mmr.2018.9353

Antifibrotic potential of bone marrow‑derived mesenchymal stem cells in biliary atresia mice

Authors:
- Jun Lei
- Yong Chai
- Juhua Xiao
- Huakun Hu
- Zhiqiang Liu
- Yu Xiao
- Lijun Yi
- Jinshi Huang
- Tianxin Xiang
- Shouhua Zhang
View Affiliations

Affiliations: Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi 330006, P.R. China, Department of Ultrasound, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, P.R. China, Department of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 3, 2018 https://doi.org/10.3892/mmr.2018.9353
Pages: 3983-3988

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Biliary atresia (BA) is a rare and severe disease that affects infants where a fibroinflammatory process destroys the bile ducts, leading to fibrosis and biliary cirrhosis, and mortality if untreated. Bone marrow‑derived mesenchymal stem cells (BMMSCs) have been considered as a promising therapy in fibrotic diseases. The aim of the present was to investigate the anti‑fibrotic roles of BMMSC transplantation in a BA mouse model. Mouse BA models were established by Rhesus rotavirus administration to neonatal mice. The results revealed that the liver enzyme and bilirubin metabolism levels, and the levels of the oxidative stress marker malondialdehyde (MDA) and the fibrosis marker were all increased in the BA model, while the liver tissue levels of superoxide dismutase and glutathione peroxidase were reduced. The hematoxylin and eosin and Masson's trichrome staining revealed severe liver fibrosis and collagen accumulation in BA livers. However, these indicators were all reversed once the BA mice were administered the BMMSC inoculation. In conclusion, the present study demonstrated the anti‑fibrotic potential of BMMSCs in BA mice, which may provide a novel approach to ameliorate the fibrotic response in BA patients.

View Figures

View References

1	Hartley JL, Davenport M and Kelly DA: Biliary atresia. Lancet. 374:1704–1713. 2009. View Article : Google Scholar : PubMed/NCBI
2	Mieli-Vergani G and Vergani D: Biliary atresia. Semin Immunopathol. 31:371–381. 2009. View Article : Google Scholar : PubMed/NCBI
3	Sira MM, Taha M and Sira AM: Common misdiagnoses of biliary atresia. Eur J Gastroenterol Hepatol. 26:1300–1305. 2014. View Article : Google Scholar : PubMed/NCBI
4	You Z, Wen J, Cheng L, Ye H and Li B: Screening of targeted genes in extrahepatic bile ducts of mice with experimental biliary atresia. Mol Med Rep. 12:4326–4331. 2015. View Article : Google Scholar : PubMed/NCBI
5	Zagory JA, Nguyen MV and Wang KS: Recent advances in the pathogenesis and management of biliary atresia. Curr Opin Pediatr. 27:389–394. 2015. View Article : Google Scholar : PubMed/NCBI
6	Li Y, Wu Q, Wang Y, Li L, Bu H and Bao J: Senescence of mesenchymal stem cells (Review). Int J Mol Med. 39:775–782. 2017. View Article : Google Scholar : PubMed/NCBI
7	Wang H, Zhang H, Huang B, Miao G, Yan X, Gao G, Luo Y, Chen H, Chen W and Yang L: Mesenchymal stem cells reverse highfat dietinduced nonalcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice. Mol Med Rep. 17:3769–3774. 2018.PubMed/NCBI
8	Sioud M, Mobergslien A, Boudabous A and Floisand Y: Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int J Oncol. 38:385–390. 2011. View Article : Google Scholar : PubMed/NCBI
9	Berardis S, Lombard C, Evraerts J, El Taghdouini A, Rosseels V, Sancho-Bru P, Lozano JJ, van Grunsven L, Sokal E and Najimi M: Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One. 9:e861372014. View Article : Google Scholar : PubMed/NCBI
10	Zhang R, Lin Z, Lui VCH, Wong KKY, Tam PKH, Lee P, Lok CN, Lamb JR, Chen Y and Xia H: Silver nanoparticle treatment ameliorates biliary atresia syndrome in rhesus rotavirus inoculated mice. Nanomedicine. 13:1041–1050. 2017. View Article : Google Scholar : PubMed/NCBI
11	Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
12	Mohanty SK, Donnelly B, Dupree P, Lobeck I, Mowery S, Meller J, McNeal M and Tiao G: A point mutation in the rhesus rotavirus VP4 protein generated through a rotavirus reverse genetics system attenuates biliary atresia in the murine model. J Virol. 91:e005102017. View Article : Google Scholar : PubMed/NCBI
13	Bezerra JA: Potential etiologies of biliary atresia. Pediatr Transplantat. 9:646–651. 2005. View Article : Google Scholar
14	Petersen C, Grasshoff S and Luciano L: Diverse morphology of biliary atresia in an animal model. J Hepatol. 28:603–607. 1998. View Article : Google Scholar : PubMed/NCBI
15	Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, Fisher J and Ogra PL: Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Research. 33:394–399. 1993. View Article : Google Scholar
16	Elmahdy NA, Sokar SS, Salem ML, Sarhan NI and Abou-Elela SH: Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl4- induced liver fibrosis in mice. Biomed Pharmacother. 89:1378–1386. 2017. View Article : Google Scholar : PubMed/NCBI
17	Cadenas E: Biochemistry of oxygen toxicity. Annu Rev Biochem. 58:79–110. 1989. View Article : Google Scholar : PubMed/NCBI
18	Asakawa T, Tanaka Y, Asagiri K, Kobayashi H, Tanikawa K and Yagi M: Oxidative stress profile in the post-operative patients with biliary atresia. Pediatr Surg Int. 25:93–97. 2009. View Article : Google Scholar : PubMed/NCBI
19	Tang N, Zhang Y, Liu Z, Fu T, Liang Q and Ai X: Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis. Biomed Rep. 5:107–112. 2016. View Article : Google Scholar : PubMed/NCBI
20	Baranova A, Lal P, Birerdinc A and Younossi ZM: Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 11:912011. View Article : Google Scholar : PubMed/NCBI
21	Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, et al: Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol. 23:252–265. 2012. View Article : Google Scholar : PubMed/NCBI
22	Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN and Iredale JP: Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut. 49:577–583. 2001. View Article : Google Scholar : PubMed/NCBI
23	Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD and Mao N: Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 105:4120–4126. 2005. View Article : Google Scholar : PubMed/NCBI
24	Jang YO, Jun BG, Baik SK, Kim MY and Kwon SO: Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol. 21:141–149. 2015. View Article : Google Scholar : PubMed/NCBI